Zhang, Ya
Luo, Dehong
Guo, Wei
Liu, Zhou
Zhao, Xinming
Article History
Received: 25 July 2022
Accepted: 3 February 2023
First Online: 27 February 2023
Declarations
:
: The authors declare that they have no potential conflicts of interest.
: This study has been approved by the local institutional review board (National GCP Center for Anticancer Drugs, The Independent Ethics Committee, No: NCC2017 G-045). All methods were performed in accordance with the relevant guidelines.